5.89
price up icon7.88%   0.43
pre-market  Pre-mercato:  5.95   0.06   +1.02%
loading

Karyopharm Therapeutics Inc Borsa (KPTI) Ultime notizie

pulisher
03:16 AM

Is Karyopharm Therapeutics Inc. (25K0) stock among top earnings plays2025 Technical Overview & Safe Capital Growth Tips - Newser

03:16 AM
pulisher
Dec 04, 2025

How Karyopharm Therapeutics Inc. (25K0) stock reacts to new regulationsTrade Volume Summary & Daily Stock Trend Watchlist - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

What makes Karyopharm Therapeutics Inc. (25K0) stock appealing to growth investorsJuly 2025 Volume & Fast Exit and Entry Strategy Plans - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Will Karyopharm Therapeutics Inc. (25K0) stock outperform global peersJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Karyopharm Therapeutics Inc. (25K0) stock split increase liquidity2025 Big Picture & Fast Gaining Stock Reports - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Karyopharm Therapeutics Inc. (25K0) stock announce special dividendMarket Growth Summary & Expert Curated Trade Ideas - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Why global investors buy Karyopharm Therapeutics Inc. (25K0) stockJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - Newser

Dec 03, 2025
pulisher
Dec 01, 2025

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Karyopharm

Dec 01, 2025
pulisher
Dec 01, 2025

Karyopharm (Nasdaq: KPTI) plans fireside chat at Piper Sandler 37th Healthcare Conference - Stock Titan

Dec 01, 2025
pulisher
Dec 01, 2025

Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference - Karyopharm

Dec 01, 2025
pulisher
Nov 30, 2025

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 30, 2025
pulisher
Nov 28, 2025

Looking at the Narrative for Karyopharm as Financing and Trial Milestones Shift the Outlook - Yahoo Finance

Nov 28, 2025
pulisher
Nov 28, 2025

Karyopharm Grows Revenue With Strong XPOVIO Sales And Partnerships - Finimize

Nov 28, 2025
pulisher
Nov 27, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Passes Below 200 Day Moving AverageWhat's Next? - MarketBeat

Nov 27, 2025
pulisher
Nov 25, 2025

Karyopharm Therapeutics (KPTI) Price Target Decreased by 11.70% to 14.11 - MSN

Nov 25, 2025
pulisher
Nov 24, 2025

[424B3] Karyopharm Therapeutics Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan

Nov 24, 2025
pulisher
Nov 21, 2025

Is Karyopharm Therapeutics Inc. stock vulnerable to regulatory risks2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why Karyopharm Therapeutics Inc. (25K0) stock trades below fair valueJuly 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Karyopharm Therapeutics Inc. stock reacts to job market dataStock Surge & AI Driven Price Predictions - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock undervalued by metrics2025 Investor Takeaways & Daily Stock Trend Watchlist - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

What momentum indicators show for Karyopharm Therapeutics Inc. stockJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why pension funds invest in Karyopharm Therapeutics Inc. (25K0) stockRate Cut & Technical Pattern Recognition Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Can Karyopharm Therapeutics Inc. stock hit record highs againGold Moves & AI Driven Stock Movement Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Karyopharm Therapeutics Inc. stock attractive for long term wealth building2025 Short Interest & Consistent Profit Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Karyopharm Therapeutics Inc. (25K0) stock sustain revenue momentumMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What’s the recovery path for long term holders of Karyopharm Therapeutics Inc.July 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Karyopharm Therapeutics Inc. (25K0) stock outperform energy sector in 2025Weekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock a top hedge fund pickQuarterly Portfolio Review & Low Risk High Win Rate Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Quantitative breakdown of Karyopharm Therapeutics Inc. recent moveMarket Performance Report & Real-Time Market Sentiment Alerts - newser.com

Nov 19, 2025
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
Capitalizzazione:     |  Volume (24 ore):